| Q34538733 | A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature |
| Q37363685 | An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL. |
| Q37331221 | Characterization of leukemias with ETV6-ABL1 fusion |
| Q58608043 | Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study |
| Q33422654 | Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21). |
| Q41528529 | Modeling ETV6-JAK2-induced leukemia: insights from the zebrafish |
| Q37369589 | Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review |
| Q53506252 | Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland. |
| Q38956273 | Pediatric T-cell acute lymphoblastic leukemia |
| Q34572279 | Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia |
| Q92045022 | SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias |
| Q36031396 | Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor |